tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Leon Wang, 11 are a BUY (78.57%), 3 are a HOLD (21.43%).
Analyst Leon Wang, currently employed at BARCLAYS, carries an average stock price target met ratio of 70.83% that have a potential upside of 37.41% achieved within 89 days.
Leon Wang’s has documented 28 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 25-Jun-2024.
Analyst best performing recommendations are on CINC (CINCOR PHARMA).
The best stock recommendation documented was for CINC (CINCOR PHARMA) at 12/7/2022. The price target of $22 was fulfilled within 33 days with a profit of $9.47 (75.58%) receiving and performance score of 22.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Dec-2022
$31
$1.94 (6.68%)
3 years 9 months 2 days ago
(12-Jan-2023)
1/2 (50%)
$1.93 (6.64%)
33
Hold Since 29-Nov-2022
$30
$0.94 (3.23%)
3 years 9 months 4 days ago
(10-Jan-2023)
2/3 (66.67%)
$1.2 (4.17%)
24
Buy Since 01-Feb-2022
$50
$20.94 (72.06%)
$30
3 years 10 months 14 days ago
(30-Nov-2022)
1/2 (50%)
$38.2 (323.73%)
188
Buy Since 01-Feb-2022
$60
3 years 10 months 15 days ago
(29-Nov-2022)
2/3 (66.67%)
$25 (71.43%)
103
Buy Since 22-Aug-2022
$53
$23.94 (82.38%)
$73
3 years 10 months 16 days ago
(28-Nov-2022)
0/2 (0%)
$38.89 (275.62%)
What Year was the first public recommendation made by Leon Wang?
